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Conclusion: Within the limitations of a retrospective study, 
our results show that the growth and shift of brain metastasis 
over time can be significant and may vary over patient 
groups. Given the typical steep dose gradient in SRS 
treatments (>10%/mm), tumour growths and shifts may have 
a significant impact on the tumour dose. Therefore, this 
phenomenon must be considered if the workup and 
treatment of SRS for brain metastasis is encompassing 
multiple days. 
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Purpose or Objective: One of the factors determining the 
size of planning target volume (PTV) margins is organ motion. 
Organ motion is comprehensively studied in adults and 
paediatric PTV margins are generally based on these data. 
We hypothesize that adult-based PTV margins are too large 
for paediatric patients because children and adults differ in 
body composition. Our aim was to compare renal and 
diaphragmatic interfractional motion in children with that in 
adults and to investigate the correlation with age and height. 
 
Material and Methods: This single-centre retrospective study 
consisted of 35 children and 35 adults who received 
thoracic/abdominal irradiation between October 2009 and 
December 2014. The mean age of children and adults was 
10.3 years (range 3.1-17.8 years) and 59.9 years (range 34.1-
94.0 years) respectively. Mean height in children and adults 
was 140 cm (range 92-184 cm) and 175 cm (160-203 cm) 
respectively. According to protocol, abdominal and/or 
thoracic Cone Beam CT (CBCT) images were acquired for 
setup verification before radiation delivery. A total of 70 
reference CT (refCT) scans, 350 paediatric CBCTs (mean 10; 
range 5-30) and 476 adult CBCTs (mean 14; range 5-27) were 
available for registration using Elekta XVI software. In order 
to assess renal and diaphragmatic motion, each CBCT was 
registered to its refCT in 2 steps; registration of: 1) the bony 
anatomy (i.e., the vertebral column), and 2) the left kidney, 
right kidney and diaphragm separately. For each individual, 
we assessed organ motion in the left-right (LR), cranio-caudal 
(CC), and anterior-posterior (AP) directions for the left and 
right kidney. Diaphragmatic motion was measured in the CC 
direction only as a surrogate for upper abdominal organ 
motion. Subsequently, for all organs the mean and standard 
deviation of the measurements in all directions were 
calculated and analysed to estimate the group systematic 
error (Σ) and the group random error (σ). The correlations 
between organ motion and age and height were investigated 
using a univariate regression analysis. 
 
Results: Interfractional organ motion in children and adults 
was different; displacements in children were notably smaller 
than in adults. Consequently, the estimated group systematic 
(Σ) and random errors (σ) for the two groups were different 
(Table 1). Within each group, no correlation was found 
between organ motion and age or height. Overall, in the CC 
direction, weak correlations were found between the patient 
random error, and age and height (Figure 1). 
 
 
 
 
 
Conclusion: Our results show that renal and diaphragmatic 
interfractional motion in children tend to be smaller than in 
adults, suggesting that abdominal PTV margins in children 
could be reduced. The difference in organ motion in the two 
groups could not completely be explained by age or height, 
indicating that further research is needed to understand the 
underlying mechanisms. 
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Purpose or Objective: We developed a new liquid fiducial 
marker (BioXmark®) for use in image-guided radiotherapy 
(IGRT). The liquid solidifies into a three dimensional (3D) 
structure after injection into tissue. A good level of marker's 
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visibility in a lung phantom using 2D and 3D x-ray imaging was 
previously shown. We report results and experiences from the 
study examining the performance (structural - and 
geometrical stability) of the liquid marker during 
radiotherapy of patients with non-small cell lung cancer 
(NSCLC) in free breathing (FB) or deep inspiration breath hold 
(DIBH). 
 
Material and Methods: Fifteen patients had markers 
implanted into the primary tumour and/or involved lymph 
nodes. Cone-beam computed tomography (CBCT) images 
were acquired daily during the course of radiotherapy (66 Gy 
/ 33 fractions). The fiducial markers were contoured 
automatically on all the daily acquired images, using a 400 
Hounsfield Units (HU) level as threshold, in the treatment 
planning system Eclipse (v. 13.0), the data was retrieved and 
analysed using Eclipse scripting API and Matlab v2014b, 
respectively. The stability of the marker inside the tumour 
and the lymph nodes was evaluated visually. The structural 
stability of the marker regarding volume and radio-opacity 
was evaluated as physical measured volume and mean HU, 
analysed over time. Furthermore the positional stability of all 
markers was analysed by weekly measurements of the change 
of the distance between marker centre position and carina, 
as a surrogate for inter-fractional variation in position of the 
tumours and the lymph nodes. 
 
Results: Two patients did not receive radiotherapy and thus 
13 patients with 29 markers were analysed (9 injected into 
tumours and 20 injected into lymph nodes). Ten patients 
were treated in DIBH and three in FB. All injected markers 
stayed in the injected site between planning and end of 
treatment. The variation in global mean HU was larger for all 
primary tumour markers (937±227 HU, mean±SD) compared 
to lymph nodes markers (921±153HU). This might be because 
tumours have a larger anatomical change/shrinkage 
compared to lymph nodes, which in turn affects the liquid 
marker. The measured sizes of the markers showed good 
stability during treatment (See Figure)  
 
 
In terms of IGRT, the markers were visible on CBCT 
throughout the treatment; DIBH related artefacts in the 
markers (elongated markers due to inter-breath hold 
variation) were observed on a few patients. Three patients 
(two DIBH and one FB) showed > 5 mm inter-fraction 
variation in marker position relative to carina, possibly due to 
tumour/lymph node shrinkage or anatomical changes. They 
were all rescanned for treatment adaptation. 
 
Conclusion: The liquid fiducial markers remained stable 
throughout the treatment course regarding position inside 
the target, physical volume and radio-opacity on CBCT. The 
BioXmark® liquid marker offers an interesting alternative to 
solid markers. 
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Purpose or Objective: The benefit of proton therapy may be 
jeopardized by dose deterioration caused by water 
equivalent path length (WEPL) variations e.g. due to inter-
fractional motion. The aim of this study was to explore 
patient- and population-specific patterns in the robustness 
towards inter-fractional motion for pelvic lymph node (LN) 
irradiation of prostate cancer patients using proton beams 
from different directions. 
 
Material and Methods: Image data sets of 18 patients 
consisting of a planning computed tomography (pCT) and 
multiple repeat CT (rCT) scans with target volumes and 
organs at risk (ORs) outlined in all scans were used. Ray path 
WEPLs were computed by averaging over beams eye view 
WEPL maps at all possible beam angle configurations (for 
both gantry and couch in 5° angle intervals) considering left 
and right LNs separately. For 0° couch angle the mean and 
the standard deviation of the WEPL differences between all 
rCTs and the pCT WEPL map were extracted for the entire 
population. Finally, single beam spot scanning proton plans 
were optimized for all gantry angles (couch angle 0°) over 
the planning target volume (PTV) generated from the clinical 
target volume (CTV) using isotropic margin configurations (3 
and 5 mm). The optimized fluence maps for the pCT for each 
beam angle were applied onto all rCTs and the dose 
distributions re-calculated, and dose differences were 
extracted. 
 
Results: The WEPL analysis for the left and right section of 
the lymph nodes showed a general pattern of least variation 
around couch angle = 0°. Furthermore it showed three 
minima across the mean of the patient WEPL maps at couch 
angle = 0° for gantry angles of 0-25°, 125-140° and 170-180° 
for the left section, as well as gantry angles of 180-220° and 
330-355° for the right section, which also appeared to be the 
angles of lowest variations among patients (Fig.1). The 
clustering analysis of the WEPL maps at couch angle = 0° 
against the angles showed for the left section of the lymph 
nodes that the patients split into three groups from which 
one group of two patients showed a clearly different pattern 
of lower variation in the lateral and posterior angles. The 
other fourteen patients were closer correlated and showed 
highest variation for the lateral angles (Fig.1). For the right 
section of the lymph nodes the patients were split into two 
groups of nine and seven patients, where the seven had a 
visibly higher variation in the posterior angles as the main 
difference. The dose calculation results showed similar 
results as for the WEPL variation, e.g. for the left LNs angles 
around 25-35°, 100-110° and 160-170° were consistently 
preferable for the bowel, bladder and rectum as well as LN 
dose deterioration. 
 
Conclusion: We have found that WEPL maps show population-
specific patterns and that there were consistent patterns in 
which angles are most robust. Similar ‘robust’ angles were 
also found in the dose/volume analysis. 
